Psoriasis
Latest News
Sustained Control Reported for Anti–IL-17, Anti–IL-23 Psoriasis Treatments
Longer follow up is with the IL-17 inhibitor bimekizumab. In a 4-year open-label extension study, the PASI 90 rate was approximately 85% in...
Clinical Review
Depression As a Potential Contributing Factor in Hidradenitis Suppurativa and Associated Racial Gaps
Depression may be a potential contributing factor to hidradenitis suppurativa in affected patients,
From the Journals
How Good are Tools to Screen for Spondyloarthritis in Patients With Psoriasis, Uveitis, IBD?
A comparison of screening tools for SpA in conditions that commonly co-occur with the disease revealed few screening tool options for patients...
Latest News
Study Evaluates Factors Driving Fatigue in Patients With Psoriasis, PsA
The study “highlights the importance of a symptom-based approach when treating psoriasis, ” the authors wrote.
News from the FDA/CDC
FDA Approves 10th Humira Biosimilar, With Interchangeability
Adalimumab-ryvk (Simlandi) is the first adalimumab biosimilar in a high-concentration formulation to receive interchangeability status from the...
From the Journals
Ixekizumab’s Final Safety Results Reported Across 25 Trials in Psoriasis, PsA, Axial SpA
Final safety results from 25 randomized clinical trials were consistent with previous reports at up to 6 years’ follow-up.
Latest News
Use of Biologics for Psoriasis Found to Confer a Survival Benefit
The study population consisted of 18,618 psoriasis cases and 55,854 controls.
Latest News
Pretreatment Lab Testing for Chronic Skin Diseases Diverges From Guidelines
In the study, a CBC was the most common pretreatment test across treatments, performed in 41%-69% of patients before starting treatment with a...
Latest News
Oral IL-23 Inhibitor Calms Moderate to Severe Psoriasis
The impact on psoriasis of higher doses of JNJ-77242113 at week 16 "was similar in magnitude to the responses seen with several of the injectable...
From the Journals
Comorbidities and Disease Type Weigh Heavily in Pregnancy Outcomes of Immune-Mediated Inflammatory Diseases
After controlling for other chronic conditions, certain immune-mediated inflammatory diseases were not associated with an increased risk for poor...
Original Research
A Cross-sectional Analysis of Regional Trends in Medicare Reimbursement for Phototherapy Services From 2010 to 2023
In this study we aimed to illustrate the most recent regional payment trends in phototherapy procedures for Medicare B patients.